These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11784871)

  • 1. Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival.
    Ueki K; Fruman DA; Brachmann SM; Tseng YH; Cantley LC; Kahn CR
    Mol Cell Biol; 2002 Feb; 22(3):965-77. PubMed ID: 11784871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling.
    Ueki K; Fruman DA; Yballe CM; Fasshauer M; Klein J; Asano T; Cantley LC; Kahn CR
    J Biol Chem; 2003 Nov; 278(48):48453-66. PubMed ID: 14504291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
    Mauvais-Jarvis F; Ueki K; Fruman DA; Hirshman MF; Sakamoto K; Goodyear LJ; Iannacone M; Accili D; Cantley LC; Kahn CR
    J Clin Invest; 2002 Jan; 109(1):141-9. PubMed ID: 11781359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
    Luo J; Field SJ; Lee JY; Engelman JA; Cantley LC
    J Cell Biol; 2005 Aug; 170(3):455-64. PubMed ID: 16043515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
    Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
    Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
    Barbour LA; Mizanoor Rahman S; Gurevich I; Leitner JW; Fischer SJ; Roper MD; Knotts TA; Vo Y; McCurdy CE; Yakar S; Leroith D; Kahn CR; Cantley LC; Friedman JE; Draznin B
    J Biol Chem; 2005 Nov; 280(45):37489-94. PubMed ID: 16166093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha.
    Hallmann D; Trümper K; Trusheim H; Ueki K; Kahn CR; Cantley LC; Fruman DA; Hörsch D
    J Biol Chem; 2003 Feb; 278(7):5099-108. PubMed ID: 12435753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
    Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class IA PI3K regulatory subunits: p110-independent roles and structures.
    Fox M; Mott HR; Owen D
    Biochem Soc Trans; 2020 Aug; 48(4):1397-1417. PubMed ID: 32677674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective insulin-induced activation of class I(A) phosphoinositide 3-kinase in PIKfyve immune complexes from 3T3-L1 adipocytes.
    Sbrissa D; Ikonomov O; Shisheva A
    Mol Cell Endocrinol; 2001 Jul; 181(1-2):35-46. PubMed ID: 11476939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
    Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
    Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K p110 alpha and p110 beta have differential effects on Akt activation and protection against oxidative stress-induced apoptosis in myoblasts.
    Matheny RW; Adamo ML
    Cell Death Differ; 2010 Apr; 17(4):677-88. PubMed ID: 19834495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversification of cardiac insulin signaling involves the p85 alpha/beta subunits of phosphatidylinositol 3-kinase.
    Kessler A; Uphues I; Ouwens DM; Till M; Eckel J
    Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E65-74. PubMed ID: 11120660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.
    Brachmann SM; Ueki K; Engelman JA; Kahn RC; Cantley LC
    Mol Cell Biol; 2005 Mar; 25(5):1596-607. PubMed ID: 15713620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recruitment of the tyrosine phosphatase Src homology 2 domain tyrosine phosphatase-2 to the p85 subunit of phosphatidylinositol-3 (PI-3) kinase is required for insulin-like growth factor-I-dependent PI-3 kinase activation in smooth muscle cells.
    Kwon M; Ling Y; Maile LA; Badley-Clark J; Clemmons DR
    Endocrinology; 2006 Mar; 147(3):1458-65. PubMed ID: 16306077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.
    Ueki K; Yballe CM; Brachmann SM; Vicent D; Watt JM; Kahn CR; Cantley LC
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):419-24. PubMed ID: 11752399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer.
    Luo J; Cantley LC
    Cell Cycle; 2005 Oct; 4(10):1309-12. PubMed ID: 16131837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.
    Mothe I; Delahaye L; Filloux C; Pons S; White MF; Van Obberghen E
    Mol Endocrinol; 1997 Dec; 11(13):1911-23. PubMed ID: 9415396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle.
    Barbour LA; Shao J; Qiao L; Leitner W; Anderson M; Friedman JE; Draznin B
    Endocrinology; 2004 Mar; 145(3):1144-50. PubMed ID: 14633976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.